Introduction
There is enormous research interest at the present time in the general field of peptide growth factors and their importance to cell proliferation in both normal and tumour cells. It is therefore no surprise that this excitement and a flurry of research activity have extended to the role of these factors in the control of preimplantation embryo development. The topic is of interest not just in fundamental biological terms but also in relation to improving both human and animal fertility and particularly in improving the quality of embryos produced by in-vitro fertilization.
The question of the role of growth factors in preimplantation development has been attacked on a broad front ranging from studies on gene expression of both growth factor ligand (the peptide growth factor itself) and its receptor in preimplantation embryos and in synchronous oviduct and uterine tissue, to gene knockout studies in which animals have been produced without functional genes for either the growth factor ligand or the receptor. These studies have been complemented by work in which the effects of particular growth factors on embryo development in culture have been examined. The present review summarizes the work carried out in these areas and attempts to draw conclusions as to the relevance of this work in improving growth of embryos in culture. There have been a number of previous general reviews in this area (Hill et al., 1987; Mercola and Stiles, 1988; Graham et al., 1990; Simmen and Simmen, 1991; Adamson, 1993; Heyner et al., 1993a; Giudice, 1994; Robertson et al., 1994; Giudice and Saleh, 1995; Harvey et al., 1995b) . This review focuses on the role of growth factors in preimplantation embryo development and in general does not consider their role in postimplantation growth. Neither does it consider their role in implantation (Harvey et al., 1995b; Simón et al., 1996) . In looking at the effects of peptide growth factors on embryos, it is essential to keep in mind that embryonic growth in vivo and in vitro is influenced by a host of other factors (for a recent comprehensive review, see Bavister, 1995) .
Problems and pitfalls of embryonic growth factor research
There are a number of problems and pitfalls that arise in relation to interpreting the results of published work on growth factors and embryos.
The 'bandwagon' problem
Because of the very great interest in growth factor research in embryos, there is a serious risk that the literature may be biased by a tendency on the part of researchers to accept marginally positive results as of great significance and ignore negative results. This problem is particularly relevant to embryo culture studies with growth factors. A related problem is the tendency to ascribe effects to growth factors when numerous other causes are possible. A number of workers have found that culture of embryos in groups in small volumes of media (Schini and Bavister, 1988; Paria and Dey, 1990; Lane and Gardner, 1992; Gardner et al., 1994; Carolan et al., 1995; Moessner and Dodson, 1995) improves embryo development. This is often cited as evidence for a paracrine effect of growth factors, but while there is tentative evidence that it may be due to growth factors (Paria and Dey, 1990) , it may have nothing to do with growth factors but rather to the release from the embryo of a myriad of other possible growth-promoting factors, such as amino acids, energy substrates, fatty acids, vitamins, etc.
The problem of limitations of current media
If media are seriously deficient in supporting embryonic growth due to the absence or toxicity of factors other than peptide growth factors, it may well be impossible to demonstrate the activity of peptide growth factors. Two examples should suffice. The hamster embryo has an absolute requirement for carbon dioxide in the medium (Carney and Bavister, 1987) ; in its absence no development can take place and no peptide growth factor can be expected to alter that. Similarly, blastocyst growth in the rabbit requires inositol (Kane, 1988; Fahy and Kane, 1992) and citrate (Gray et al., 1992) , and blastocyst growth will be drastically limited by the absence of these factors. On the other hand, there may be instances where poor culture conditions may be compensated by addition of growth factors (Paria and Dey, 1990) .
The problem of the mouse embryo as a model
Much of the work on the effects of growth factors on embryos in culture has been carried out on mouse embryos, and researchers have tried to show an effect of growth factors on mouse embryo development in culture. This is reasonable if one is trying to show that mouse embryos can respond to growth factors in some developmental fashion, such as increased protein synthesis or increased cell number, or change in protein synthesis pattern etc. However, given that 1-and 2-cell mouse embryos will develop in high proportions to blastocysts in simple media without amino acids, vitamins, protein or growth factors and that the mouse blastocyst has about the same protein and dry matter contents as the 1-cell stage (Brinster, 1967; Schiffner and Spielmann, 1976; Turner et al., 1992) , it is clear that the mouse embryo is not the most promising model in which to study the effects of growth factors. It is possible that even in culture with defined media mouse embryos obtain growth factors from autocrine and paracrine secretion of growth factors by the embryos themselves. However, species such as rabbit, sheep and cattle, in which protein content as well as cell number increases markedly during the preimplantation period (Wright et al., 1981 (Wright et al., , 1983 Morgan and Kane, 1993) , may offer more promising material for the investigation of growth factors. Use of these species does bring other problems, however, not least the problem of cost.
Problems in the use of gene knockout to study growth factor requirements Gene knockout is the approach whereby molecular biological techniques, usually combined with embryonic stem (ES) cell technology, are used to create mice in which a particular gene has been disrupted to produce a null mutation. Mice can then be bred to be homozygous for the null mutation, with the result that the mouse has no working copy of the particular gene. This can be used to produce mice which are homozygous for null mutations in either the gene for a growth factor ligand or its receptor. This area has been recently reviewed (Gatherer, 1993; Bronson and Smithies, 1994; Melton, 1994; Fässler et al., 1995; Ryffel, 1995; Shastry, 1995) . The problem that arises here is that while inhibition of preimplantation development by a gene knockout of a growth factor or its receptor indicates that the growth factor in question is essential for preimplantation development, failure to inhibit development is not proof that the growth factor is unimportant for preimplantation embryo growth. There may be redundancy of function in that growth factors may substitute for each other (Gospodarowicz et al., 1975) . Until mice with multiple growth factor gene knockouts become available (Shastry, 1995) , it is impossible to prove from gene knockout studies that a particular growth factor has no role. However, it is clear that this approach is an extremely promising one.
Growth factors and growth factor families
A very useful general reference to growth factors and cytokines is the book edited by Nicola (1994) .
Epidermal growth factor family
Members of the epidermal growth factor (EGF) family include EGF, amphiregulin, neuregulin and transforming growth factor-α (TGF-α) (reviewed by Carpenter and Zendegui, 1986; Derynck, 1986 Derynck, , 1990 Campbell and Cooke, 1990; Werb, 1990; Carpenter and Wahl, 1991; Wiley et al., 1995; Lemke, 1996) . These growth factors are structurally related and they all share similarities in amino acid sequence and in their ability to mimic EGF-like activities by binding to the EGF receptor, the c-erb B proto-oncogene product. The activation of the EGF receptor, after binding of any one of the above ligands, evokes intracellular protein tyrosine phosphorylation, including rapid receptor auto-phosphorylation. EGF itself is one of the most biologically potent and best characterized of this family as to its physical, chemical and biological properties. It has wide ranging actions in many tissues, stimulating both cell proliferation and differentiation (Adamson, 1990b) . A different type of role has been suggested for heparin-binding epidermal growth factor (HB-EGF) at implantation in the mouse; interaction between HB-EGF on the uterine luminal epithelium at the site of blastocyst apposition and heparan sulphate proteoglycan on blastocyst trophectoderm cells may mediate blastocyst adhesion (Raab et al., 1996) . In this case, HB-EGF may be functioning as a juxtacrine growth factor.
Insulin and the insulin-like family of peptide growth factors
The insulin-like family of growth factors is made up of insulin-like growth factors (IGF)-I and -II (reviewed by Heyner et al., 1989; Lowe, 1991; Rechler and Nissley, 1991; Werner et al., 1991; Kaye et al., 1992; Krywicki and Yee, 1992; Quin, 1992; Schultz et al., 1992; Heyner et al., 1993b; LeRoith et al., 1993; Murphy and Barron, 1993; Simmen et al., 1993; Heyner and Garside, 1994; Binoux, 1995; Benito et al., 1996; Stewart and Rotwein, 1996) . Members of the family are related by sequence and have insulin-like metabolic effects. The two IGFs, IGF-I and IGF-II, have structural homology with proinsulin. Each member of the family binds to its own specific cell surface receptor and also with reduced affinity to the heterologous receptors. Thus, there is a considerable degree of overlap of function in that insulin and IGF can mimic each other's actions to a certain extent. The insulin and IGF-I receptors are similar to receptor tyrosine kinases, but a tyrosine kinase domain is lacking in the IGF-II receptor type which is identical to the mannose-6-phosphate receptor (Nissley et al., 1993) .
Insulin promotes glucose uptake by cells and is also a mitogen. IGF-I stimulates uptake of both amino acids and glucose and acts as progression factor in the cell cycle; in its absence cell cycle length may be prolonged (Rozengurt, 1986; Lowe, 1991) . The primary function of IGF-II may be to control growth rate during fetal development (Gluckman, 1986; Binoux, 1995) . IGF in plasma circulate bound to IGF-binding proteins (IGFBP), of which there are at least six (reviewed by Clemmons, 1991 Clemmons, , 1993 Krywicki and Yee, 1992; Murphy and Barron, 1993; Binoux, 1995) . A major role of IGFBP may be the delivery of the IGF to a target tissue, and they may also modulate the biological actions of IGF by competing for and interacting with their receptors (Clemmons, 1993) .
Transforming growth factor-β family
The transforming growth factor-β (TGF-β) family consists of a group of structurally homologous dimeric proteins that derives its name from the potency of these proteins in phenotypically transforming fibroblasts in vitro so that their growth becomes anchorage independent (reviewed by Roberts and Sporn, 1991; Akhurst et al., 1992; Mummery and van den Eijnden-van Raaij, 1993; Kingsley, 1994; Shull and Doetschman, 1994; Matzuk, 1995; Lawrence, 1996; Teixeira and Donahoe, 1996) . Members of this family include five isoforms (three mammalian) of TGF-β [TGF-β(1-5)], inhibins, activins, bone morphogenetic proteins (BMP) and Müllerian inhibiting substance. Unlike most other peptide growth factor receptors, TGF-β receptors are not tyrosine kinase receptors but rather serine/threonine kinases (Wrana et al., 1994) . Depending on the nature of the target cells, TGF-β may inhibit or stimulate cell proliferation and induce a variety of other cellular effects in many tissues. These additional diverse biological functions include tissue remodelling, extracellular matrix formation, control of cell surface molecules and immunomodulation.
Platelet-derived growth factor
Platelet-derived growth factor (PDGF) consists of dimers of either A (17 kDa), B (16 kDa) or AB chains linked via disulphide bonds (reviewed by Raines et al., 1991; Heldin, 1992; Benito and Lorenzo, 1993; Khachigian and Chesterman, 1993; Claesson-Welsh, 1994) . The B chain is almost identical to part of the sis oncogene product. PDGF is regarded as an initiating factor in the cell cycle in that it stimulates the advance of quiescent cells from G 0 to G 1 (Rozengurt, 1986) . The role of PDGF in development has been briefly reviewed (Palmieri et al., 1993; Betsholtz, 1995) .
Fibroblast growth factor family
The fibroblast growth factor (FGF) family is currently known to contain at least nine members, FGF-1 (formerly acidic FGF), FGF-2 (formerly basic FGF), FGF-3 (int-2), FGF-4 (Kaposi's FGF), FGF-5, FGF-6, FGF-7 (keratinocyte growth factor), FGF-8 (androgen-inducible growth factor) and FGF-9 (reviewed by Baird and Böhlen, 1991; Wright et al., 1993; Baird, 1994; Blanquet, 1996) . The FGF family has at least four different genes coding for high-affinity receptors (Jaye et al., 1992; Baird, 1994) as well as low-affinity receptor sites consisting of cell surface heparan sulphate proteoglycans (Baird, 1994) .
Cytokines
There are a number of general reviews on the role of cytokines in embryonic development Arceci et al., 1992b; Ben-Rafael and Orvieto, 1992; Hill, 1992; Haimovici and Anderson, 1993a; Robertson et al., 1994; Simón et al., 1995 Simón et al., , 1996 Hunt et al., 1996) . Leukaemia inhibitory factor (LIF) is a cytokine that was originally discovered on the basis of two major actions: its ability to inhibit proliferation of a leukaemic cell line, and also to inhibit differentiation of embryonic stem cells. Since then, it has been discovered to have a very wide range of biological functions (reviewed by Hilton and Gough, 1991; Chang and Gough, 1992; Dexter et al., 1992; Fry, 1992; Patterson, 1994; Stewart, 1994) . LIF, along with interleukin-6, has been the subject of a Ciba Foundation Symposium (Bock et al., 1992) . LIF and interleukin-6, together with ciliary neurotrophic factor (CNTF) and oncostatin M, belong to a closely related family of cytokines with similar receptor molecules (see review by Barton, 1996) .
Colony-stimulating factor-1 (CSF-1) is a homodimeric glycosylated cytokine (reviewed by Pampfer et al., 1991; Arceci et al., 1992b) . Granulocyte-macrophage colonystimulating factor (GM-CSF) and granulocyte colonystimulating factor control production of blood cells such as granulocytes and macrophages (reviewed by Metcalf, 1985; Rapoport et al., 1992; . They also have actions on non-haematopoietic cells. Tumour necrosis factor-α (TNF-α) was originally discovered due to its capacity to cause tumour necrosis, but there is evidence that it has other roles (reviewed by Vassali, 1992; Hunt, 1993; Beutler and van Huffel, 1994; Terranova et al., 1995; Wride and Sanders, 1995; . Other cytokines such as interleukins and interferons may play important parts in reproduction (Ben-Rafael and Orvieto, 1992; Hill, 1992; Haimovici and Anderson, 1993a; Hertzog et al., 1994; Kitamura et al., 1994) . There is particular interest in the role of interferons in maternal recognition of pregnancy since it was discovered that trophoblastic signalling proteins produced by sheep and cattle embryos are interferons (reviewed by Roberts et al., 1992a,b) .
Another area of growing interest in relation to cytokines is associated with the discovery that many of them, as well as possessing the usual type of membrane-bound receptor, also have soluble receptors released into body fluids in high concentrations (reviewed by Rose-John and Heinrich, 1994) . Some of these may yet be found to have reproductive importance. A general review of the relevance of cytokines to embryonic development and pregnancy is that of Robertson et al. (1994) . Table I summarizes much of the evidence available for the presence of growth factor ligands and their receptors in mouse preimplantation embryos and reproductive tract tissues; Table II summarizes the same information for the human; Table III summarizes information on other laboratory animals (mainly rabbit and rat) and non-human primates; Table IV provides information on farm animals. The literature on this topic is voluminous and the coverage presented here does not pretend to be complete; this is particularly true for the expression of factors in the maternal reproductive tract. Much of the evidence comes from reverse transcriptase-polymerase chain reaction (RT-PCR) studies on expression of mRNA; other types of evidence include binding studies, immunofluorescence and immunocytochemistry studies, and even studies on production of growth factor by cultured embryos. The methodology of PCR and RT-PCR as applied to preimplantation embryos has been described and reviewed in a number of articles (Lader and Artzt, 1993; Zimmerman and Schultz, 1994; Collins and Fleming, 1995; Rambhatla et al., 1995) . A word of caution is necessary: there is some evidence that the RT-PCR techniques are so sensitive that they may amplify and detect messages from 'non-expressing' tissues (Gaudette and Crain, 1991) .
Expression of growth factors and their receptors by preimplantation embryos, oviduct and uterus
In commenting on these results, the emphasis here is on the effects on the embryo and not on the effects of the embryo on the maternal tract. From that viewpoint, a number of points emerge from these studies: (i) there appear to be a large number of growth factors and their receptors produced by both preimplantation embryos and the maternal tract; (ii) there are a number of interesting situations where growth factor ligand is produced by the maternal tract (but not the embryo) and the appropriate receptor is present on the embryo. This applies particularly to EGF and to CSF-1 for mouse cleavage and blastocyst stages, and may also apply to TNF and LIF for human blastocysts. It must be realised, however, that TGF-α, which acts on the EGF receptor, is expressed by mouse cleavage and blastocyst stages and thus autocrine as well as paracrine actions are possible for the EGF family; (iii) the possibility for autocrine activity is present in other cases where the embryo expresses both growth factor ligand and receptor, e.g. for IGF-II and PDGF; (iv) there are a number of cases where there is evidence for both receptor and ligand presence in the embryo and the ligand is also produced by the reproductive tract (e.g. FGF for mouse blastocysts), thus indicating that both autocrine and paracrine activities are possible. EGF = epidermal growth factor; TGF = transforming growth factor; HB-EGF = heparin-binding epidermal growth factor; IGF = insulin-like growth factor; FGF = fibroblast growth factor; PDGF = platelet-derived growth factor; LIF = leukaemia inhibitory factor; CSF = colony-stimulating factor; GM-CSF = granulocyte-macrophage colony-stimulating factor; TNF = tumour necrosis factor. + = evidence for presence of growth factor ligand or receptor; -= failure to detect ligand or receptor; a blank space means that no information was available to the reviewers. a Superscript numbers indicate the following references: 1 Adamson (1990a,b) , 2 Adamson et al. (1991) , 3 Arceci et al. (1989) , 4 Arceci et al. (1992a) , 5 Arceci et al. (1992b) , 6 Bartocci et al. (1986) , 7 Brown et al. (1989) , 8 Choudhuri and Wood (1993) , 9 Conquet and Brulet (1990), 10 Croteau et al. (1995) , 11 Dalton et al. (1994) , 12 Das et al. (1994) , 13 Das et al. (1995) , 14 Das et al. (1992) , 15 De et al. (1993) , 16 Doherty et al. (1994) , 17 Harvey and Kaye (1991a) , 18 Harvey and Kaye (1991b) , 19 Heyner et al. (1993a,b) , 20 Huet-Hudson et al. (1990) , 21 Hunt (1993) , 22 Hunt et al. (1993) , 23 Jacobs et al. (1992) , 24 Kapur et al. (1992) , 25 Roby et al. (1996) , 26 Murray et al. (1990) , 27 Palmieri et al. (1992) , 28 Paria et al. (1993) , 29 Paria et al. (1994a) , 30 Rappolee et al. (1988) , 31 Rappolee et al. (1990) , 32 Rappolee et al. (1994) , 33 Riego et al. (1995) , 34 , 35 Roelen et al. (1994) 36 Roby and Hunt (1995) , 37 Sanford et al. (1992) , 38 Shen and Leder (1992) , 39 Slager et al. (1991) , 40 Tamada et al. (1991) , 41 Wiley et al. (1992) : note very low levels at 2-cell stage, 42 Wordinger et al. (1992) , 43 Wordinger et al. (1994) , 44 Yamamoto et al. (1992) , 45 Campbell et al. (1992) , 46 Campbell et al. (1990) , 47 Smith et al. (1993) , 48 Robertson et al. (1996) , 49 Tong et al. (1996) , 50 Schultz et al. (1992) , 51 Dardik et al. (1992) , 52 Rappolee et al. (1992) , 53 Yang et al. (1995) , 54 Yang et al. (1996) , 55 Takacs and Kauma (1996) . Interferon receptor + 20 EGF = epidermal growth factor; TGF = transforming growth factor; IGF = insulin-like growth factor; FGF = fibroblast growth factor; PDGF = platelet-derived growth factor; PDGFR = platelet-derived growth factor receptor; LIF = leukaemia inhibitory factor; CSF = colony-stimulating factor; GM-CSF = granulocyte-macrophage colony-stimulating factor; TNF = tumour necrosis factor. + = evidence for presence of growth factor ligand or receptor; ± = evidence is equivocal; -= failure to detect ligand or receptor; a blank space means that no information was available to the reviewers. a Superscript numbers indicate the following references: 1 Giacomini et al. (1995) , 2 Arici et al. (1995) , 3 Charnock-Jones et al. (1994) , 4 Chen et al. (1995) , 5 Chia et al. (1995) , 6 Delage et al. (1995 ), 7 El-Danasouri et al. (1993 , 8 Frank et al. (1995) , 9 Gao et al. (1995) , 10 Haining et al. (1991) , 11 Hemmings et al. (1992) , 12 Horowitz et al. (1993) , 13 Hunt et al. (1992) , 14 Imai et al. (1995) , 15 Kanzaki et al. (1994) , 16 Pampfer et al. (1992) , 17 Pfeifer and Chegini (1994) , 18 Pollard et al. (1991) , 19 Rusnati et al. (1990) , 20 Russell et al. (1993) , 21 Sharkey et al. (1995) , 22 Tabibzadeh and Babaknia (1995) , 23 Terranova et al. (1995) , 24 Vogiagis(1996) , 25 Zolti et al. (1991) , 26 Arici et al. (1996) , 27 Cullinan et al. (1996) , 28 De los Santos et al. (1996) , 29 Smotrich et al. (1996) , 30 Österlund et al. (1996) , 31 Kauma et al. (1990) , 32 Simón et al. (1993a) , 33 Simón et al., (1993b) , 34 Srivastava et al. (1996) , 35 van Eijk et al. (1996) , 36 Watson et al. (1994) , 37 Watson et al. (1996) .
In surveying this picture, one is struck by the enormous complexity and one has the feeling that this is an example of how evolution works. There are an enormous number of possible mechanisms controlling embryonic development which under present circumstances may appear redundant and useless but under drastically changed environmental circumstances might have life-saving and speciespreserving effects.
Effects of gene knockout of growth factors and their receptors on preimplantation embryo development
A considerable body of work has accumulated on the effects of gene knockout of growth factors and their receptors on development in the mouse, and this work has included information on whether a null mutation for a particular growth factor or receptor is compatible with normal development throughout the preimplantation period. The methodology of gene knockout (Fässler et al., 1995) , its relevance to studies of development (Gatherer, 1993; Nishimori and Matzuk, 1996) and implantation (Tabibzadeh and Babaknia, 1995) , and the whole area of the effects of gene knockout in general (Shastry, 1994 (Shastry, , 1995 have been reviewed. The effects of gene knockout of both growth factor ligand and receptor have been investigated in many cases. However, for the knockout to shed light on the need for a particular growth factor during the preimplantation period, gene deletions which involve the growth factor receptor are the most informative; gene deletions which involve the ligand are likely to be less informative for preimplantation embryos since one can expect that maternal growth factors may substitute for missing embryonic growth factors, at least in vivo. It would be interesting to see if adult mice with particular growth factor genes deleted support early embryonic development. As yet, such studies are rare both because of the newness of the methodology but also because many growth factor deletions interfere drastically with postimplantation and postnatal development and viability. One exception is the study showing the need for maternal LIF for blastocyst implantation .
In the EGF family, the effects of knockout of the EGF receptor (Miettinen et al., 1995; Sibilia and Wagner, 1995; Threadgill et al., 1995) , the neuregulin receptors erbB2 and erbB4 (Gassmann et al., 1995; and the neuregulin ligand (Meyer and Birchmeier, 1995) have been examined. In almost all cases there appeared to be no obvious effect on preimplantation development, except that knockout of the receptor in the CF-1 strain (but not in the 129/Sv or CD-1 strains) resulted in peri-implantation death due to degeneration of the inner cell mass (Threadgill et al., 1995) . This suggests that the EGF receptor may play an important role in inner cell mass formation in some strains of mice. TNF-α + (rat) 7 EGF = epidermal growth factor; IGF = insulin-like growth factor; FGF = fibroblast growth factor; TGF = transforming growth factor; LIF = leukaemia inhibitory factor; TNF = tumour necrosis factor. + = evidence for presence of growth factor ligand or receptor; -= failure to detect ligand or receptor; a blank space means that no information was available to the reviewers. a Superscript numbers indicate the following references: 1 Hofmann and Anderson (1990) , 2 Yang et al. (1994) , 3 Carlone and Rider (1993) , 4 Carlsson and Billig (1991), 5 Carlsson et al. (1993) , 6 Zhang et al. (1994) , 7 Yelavarthi et al. (1991) , 8 Ace and Okulicz (1995), 9 Fazleabas et al. (1994) , 10 Paria et al. (1994b) , 11 Hrabé de Angelis et al. (1995) , 12 Gründker and Kirchner (1996) , 13 Yang et al. (1996) . 
Insulin receptor FGF-2 (bFGF) Interferon receptor + (sheep) 18 EGF = epidermal growth factor; TGF = transforming growth factor; HB-EGF = heparin-binding epidermal growth factor; NGF = nerve growth factor; IGF = insulin-like growth factor; FGF = fibroblast growth factor; PDGF = platelet-derived growth factor; LIF = leukaemia inhibitory factor; CSF = colony-stimulating factor. + = evidence for presence of growth factor ligand or receptor; -= failure to detect ligand or receptor; a blank space means that no information was available to the reviewers. Charpigny et al. (1988) , 15 Charlier et al. (1991) , 16 Leaman and Roberts (1992) , 17 Doré et al. (1996) , 18 Russell et al. (1993) , 19 Riley et al. (1994) , 20 Vaughan et al. (1992) : presence in blastocyst was stage-dependent, 21 Chastant et al. (1994) , 22 Tuo et al. (1995) , 23 Zhang et al. (1992a) , 24 Swanchara et al. (1995) , 25 Hofig et al. (1991) , 26 Kim et al. (1995) , 27 Ko et al. (1991) , 28 Anegon et al. (1994) , 29 Zhang et al. (1992b) , 30 Letcher et al. (1989) , 31 Ko et al. (1994) , 32 Wiseman et al. (1992) , 33 Grünig and Antczak (1995) , 34 Lennard et al. (1995) , 35 Lea et al. (1995) , 36 Gupta et al. (1996) , 37 Kirby et al. (1996) .
In the IGF family, the effects of knockout of the IGF-I ligand Powell-Braxton et al., 1993) , the IGF-I receptor , the IGF-II gene and the IGF-II receptor ) have been investigated. There is no indication that any of these knockouts interferes with preimplantation development, suggesting that neither IGF-I, IGF-II or their receptors play a major role in preimplantation development. However, as discussed already, these negative results should be interpreted with caution.
In the TGF-β family, the effects of knockout of the TGF-β1 (Shull et al., 1992; Shull and Doetschman, 1994; Matzuk, 1995) , TGF-β3 (Proetzel et al., 1995) , Müllerian inhibiting substance (MIS; Behringer et al., 1994) , BMP-7 (Hofmann et al., 1996) , inhibins (Matzuk et al., 1992) , activins (Matzuk et al., 1995a,b) and activin receptor (Matzuk et al., 1995a) have been examined, again with no obvious effects on preimplantation development. However, studies on TGF-β receptor do not appear to have been carried out, so there is no information on the need for maternal TGF-β for preimplantation embryo development.
Disruption of the PDGF-B growth factor and its receptor PDGFβ does not interfere with preimplantation development (Levéen et al., 1994; Soriano, 1994) . However, since the PDGFα receptor can bind both PDGF-A and B it is possible that the presence of PDGFα compensates for the absent PDGFβ. Disruption of the vascular endothelial growth factor (VEGF; Carmeliet et al., 1996) or its receptors (Fong et al., 1995; Shalaby et al., 1995) does not prevent preimplantation development.
In the FGF family, the effects of knockout of the FGF receptor-1 and the FGF-4 genes have been examined. Deletion of the FGF receptor-1 did not inhibit preimplantation growth but did interfere with early postimplantation growth (Deng et al., 1994; Yamaguchi et al., 1994) . Deletion of the FGF-4 gene did not interfere with in-vivo preimplantation development, but null FGF-4 embryos in culture showed very limited proliferation of the inner cell mass (Feldman et al., 1995) . Addition of FGF-4 ligand to the culture medium rescued growth and differentiation of the inner cell mass. This work is of such crucial importance in indicating an essential direct role for a peptide growth factor in very early embryonic growth that it is imperative that it be confirmed by other workers. Deletion of the FGF-3 and FGF-5 genes had no effect on development (Mansour et al., 1993; Hébert et al., 1994) .
Maternal LIF is essential for blastocyst implantation, but the null mutation embryos themselves are viable provided they are transferred to a host mother producing LIF . It has been suggested that LIF synthesis is required both by the uterus for decidualization and by the blastocyst for implantation (Stewart, 1994) . However, mouse embryos without a LIF receptor gene (LIFRβ) can implant and develop to term, albeit at a reduced rate (Ware et al., 1995) . On the other hand, overexpression of the LIF gene in mice inhibits gastrulation of postimplantation embryos (Conquet et al., 1992) . Embryos with the related cytokine, CNTF, inactivated give rise to adult mice (Sendtner et al., 1994) , as do double knockout embryos with both CNTF and LIF inactivated (Sendtner et al., 1996) . Mice without the interleukin-6 (Kopf et al., 1994) and the TNF receptor-1 (TNFR1 genes (Rothe et al., 1992) develop normally and are fertile after interbreeding, indicating that neither the interleukin-6 nor the TNFR1 gene is essential for embryogenesis. Mice also develop normally without the TNFR2 gene (Erickson et al., 1994) .
The results with gene knockout studies in relation to growth factors and embryos may be summarized as follows: (i) as yet gene knockout studies provide no evidence that growth factors affect cleavage of preimplantation embryos or early blastocyst cavitation, (ii) the only factors found so far which may be involved in blastocyst growth/periimplantation/early postimplantation development are FGF and, in some strains of mice, EGF or TGFα and (iii) maternal LIF is essential for implantation. A necessary note of caution must be repeated: absence of evidence for an essential role from knockout studies on single growth factor ligand or receptor genes does not prove that growth factor stimulation is unnecessary for preimplantation development.
Effects of addition of growth factors to embryo culture media on preimplantation embryo development
A large number of studies has been carried out on the effects of growth factors on preimplantation embryo development in culture. It seems clear that growth factors can affect embryo development in vitro but what is not so clear is the extent to which future viability of the embryos is affected by growth factor stimulation in culture. Most work has been carried out in the mouse. EGF appears to have little effect on mouse preimplantation embryo cell proliferation (Menino et al., 1989; Wood and Kaye, 1989; Colver et al., 1991) other than an inhibitory effect at high (100 ng/ml) concentrations (Goldman et al., 1993) . However, in mouse embryos cultured under stressful conditions, i.e. as single embryos per culture drop, Paria and Dey (1990) found that EGF and its related growth factor, TGF-α, stimulated development of 2-cell embryos to blastocysts. There is also evidence that EGF and TGF-α stimulate in-vitro expansion of a proportion of mouse blastocysts; neutralizing antibodies to EGF and TGF-α inhibit this effect (Dardik and Schultz, 1991) . Brice et al. (1993) reported that mouse blastocyst cavitation was accelerated by monoclonal and polyclonal antibodies to EGF receptor and delayed by antisense RNA and antisense deoxyoligonucleotides to EGF receptor. There was no significant effect of any treatment, with the exception of the polyclonal antibody, which significantly increased cell number. The authors interpreted the data as indicating that antibody binding to EGF receptor activated the receptor, thus stimulating development, but the antisense treatments inhibited receptor synthesis, thus inhibiting development. Muzikova and Clark (1995) found that EGF increased trophoblast outgrowth from mouse blastocysts implanting in vitro. Morita et al. (1994) found that EGF treatment of mouse embryos cultured to blastocysts improved implantation rate after transfer. These results are in contrast to an earlier report (Caro et al., 1987) indicating that, while treatment with a serum supplement containing EGF (Nu-Serum) improved development to blastocysts and implantation rate after transfer, it did not increase the proportion of normal fetuses. Both EGF and TGF-α have been reported to stimulate overall protein synthesis (Wood and Kaye, 1989; Werb, 1990) , and TGF-α also stimulates protein secretion into the blastocoele (Dardik et al., 1993) . Dardik et al. (1992) found that TGF-α stimulates protein synthesis by isolated mouse inner cell masses. TGF-α has also been found to affect formation of specific blastocyst proteins, including the b subunit of an F o ATPase and DNA polymerase α (Babalola and Schultz, 1995) . A very interesting effect of EGF, in conjunction with LIF, is to stimulate proteinase expression by mouse blastocysts in culture (Harvey et al., 1995a) , suggesting that it may play a role in implantation. Related to this may be the finding that EGF stimulates plasminogen activator secretion by mouse and human (Khamsi et al., 1996) blastocysts. In rabbits, Hrabé de Angelis and Kirchner (1993a) found that TGF-α but not EGF stimulated blastocyst growth. In cattle, EGF has been reported to stimulate blastocyst formation (Yang et al., 1993; Lee and Fukui, 1995) .
There have been extensive studies, particularly in the mouse, of the effects of insulin and the IGF on preimplantation embryos in culture. Insulin (Harvey and Kaye, 1990; Gardner and Kaye, 1991) , IGF-I (Harvey and Kaye, 1992b; Rappolee et al., 1992) and IGF-II (Harvey and Kaye, 1992a; Rappolee et al., 1992) have been reported to stimulate cell proliferation and blastocyst formation in mouse embryos in culture. Stimulation of cell proliferation was mainly in the inner cell mass in all cases, and the receptors involved appeared to be the specific receptor for each growth factor. In contrast, Parkin and Schofield (1996) found no effect of insulin, IGF-I or IGF-II on the 2-cell block in mouse embryos, and Colver et al. (1991) found no effect of insulin on cell number or blastocyst hatching in the mouse. In studies on embryos cultured as single embryos per culture drop, Paria and Dey (1990) found no effect of IGF-I on development of 2-cell mouse embryos to blastocysts.
One of the most interesting studies on the effects of IGF peptides on mouse embryo development is that of Rappolee et al. (1992) using antisense oligonucleotides to IGF-II. Mouse embryos treated in culture with antisense oligonucleotides to IGF-II had decreased cell numbers and blastocyst formation as compared to embryos treated with sense oligonucleotides. Simultaneous treatment of the embryos with IGF-II almost completely abolished the inhibitory effects of the antisense oligonucleotide. As stated already above for the work of Feldman et al. (1995) with FGF-4 and gene knockout embryos, this work (Rappolee et al., 1992 ) is of such crucial importance in showing an essential role for a growth factor in early embryonic development that it is imperative that it be confirmed by other workers. These experiments, when taken together with studies in the same and other papers showing preimplantation embryo expression of IGF-II, provide very strong evidence for an autocrine role for IGF-II in mouse preimplantation development.
Insulin Kaye, 1988, 1991b) and IGF-I (Harvey and Kaye, 1991b; Smith et al., 1993) were also found to stimulate overall protein synthesis in mouse embryos. In contrast to the situation obtaining for stimulation of cell proliferation, where insulin and IGF-I appeared to act each via its own receptor, effects on protein synthesis were mediated by the insulin receptor (Harvey and Kaye, 1992c) . There is also evidence (Shi et al., 1994) for effects, both stimulatory and inhibitory depending on the protein, on synthesis of specific proteins by both 8-cell mouse embryos and blastocysts (for a thorough review on this topic in mouse embryos, see Kaye et al., 1992) . In pigs, insulin has been reported to stimulate blastocyst expansion and protein synthesis (Lewis et al., 1992) and cause a transient increase in growth of isolated inner cell masses (Hochereau-de Reviers and Perreau, 1993) ; IGF-I has also been reported to stimulate protein synthesis in isolated embryonic disks (Estrada et al., 1991) and to exhibit stage-dependent effects on expression of the cytochrome P450 aromatase gene in pig blastocysts (Ko et al., 1994; Green et al., 1995) . In contrast to these studies in pigs, Lee and Fukui (1995) did not find any marked effect of IGF-I on cattle embryos in a defined culture medium.
TGF-β1 has been found to stimulate cell proliferation in cavitating mouse embryos (Lim et al., 1993) , and in conjunction with EGF to rescue mouse embryos from the detrimental effects of culture in isolation in relatively large volumes of medium (Paria and Dey, 1990) . Like TGF-α, TGF-β has also been found to affect formation of specific blastocyst proteins, including the b subunit of an F o ATPase and DNA polymerase α (Babalola and Schultz, 1995) . In contrast, in rabbits, Hrabé de Angelis and Kirchner (1993b) found no effect of TGF-β1 on blastocyst growth and, in pigs, Hochereau-de Reviers and Perreau (1993) found no effect on isolated inner cell masses. In cattle, Larson et al. (1992b) reported that TGF-β1 and bFGF synergistically promote embryo development during the fourth cell cycle in vitro, and Yang et al. (1993) found that TGF-β1 promotes increased blastocyst formation. In contrast, Lee and Fukui (1995) found no effect of TGF-β1 on cattle embryo development in culture.
Only a limited amount of work has been carried out on the effect of PDGF in embryo culture. In mice, Colver et al. (1991) found no effect of PDGF on cell number or blastocyst hatching, but Muzikova and Clark (1995) found that PDGF increased trophoblast outgrowth from mouse blastocysts. In cattle, Larson et al. (1992a) have reported that PDGF stimulates development of bovine embryos during the fourth cell cycle, while Yang et al. (1993) found that it increased development to morulae and blastocyst stages but did not increase blastocyst cell number. In an in-vitro maturation and fertilization situation, Eckert and Niemann (1996) found that addition of PDGF to oocyte maturation or embryo culture media had no significant effect on embryo development but that addition to a defined fertilization medium improved embryo development to that seen in serum-supplemented medium. In pigs, PDGF has also been reported to cause a transitory increase in protein synthesis by isolated embryonic disks (Hochereau-de Reviers and Perreau, 1993) .
Addition of FGF-4 to the culture medium has been reported to rescue mouse embryos with FGF-4 gene knockouts (Feldman et al., 1995) . Menino et al. (1989) also found a mitogenic action of FGF on normal preimplantation mouse embryos. Addition of FGF-4 to immunosurgically isolated inner cell masses in culture stimulated outgrowth of endoderm cells (Rappolee et al., 1994) . In contrast, Colver et al. (1991) found no effect of FGF on mouse embryos. In rabbits, FGF has been reported to stimulate growth of day 6 blastocysts (Hrabé de Angelis and Kirchner, 1993b; Hrabé de Angelis et al., 1995) but not growth of day 5 or day 7 blastocysts. In cattle, FGF is also reported to stimulate embryo development in culture (Larson et al., 1992b; Lee and Fukui, 1995) .
In mouse embryos, Lavranos et al. (1995) found that LIF improved development to hatched blastocysts, and increased trophoblast outgrowth and embryo survival after transfer, while Harvey et al. (1995b) found that LIF stimulated secretion of proteinases by blastocysts. Addition of LIF to culture medium stimulated development of sheep embryos to hatched blastocysts and also stimulated growth of parthenogenetic and normal cattle morulae and blastocysts (Fukui and Matsuyama, 1994; , but had no effect on cleavage-stage embryos. The stimulatory effect shown by was only seen in serum-free medium. Han et al. (1995) found that LIF improved hatching of cattle blastocysts. Jurisicova et al. (1995) found no beneficial effect of LIF on human blastocysts in medium supplemented with human serum but, in contrast, when serum-free medium was used, Dunglison et al. (1996) found that LIF stimulated blastocyst formation.
In mice, Pampfer et al. (1994b) found that TNF-α inhibited cell proliferation in mouse and rat (Pampfer et al., 1994a (Pampfer et al., , 1995 blastocysts. In rat embryos this decrease was reversed by addition to the culture medium of antisense (but not sense) oligonucleotides to the TNFα Rp60 receptor (Pampfer et al., 1995) . Another cytokine, CSF-1, has been reported to inhibit development of 2-cell mouse embryos to blastocysts (Hill et al., 1987) , whereas Pampfer et al. (1991) reported stimulation of blastocyst formation. This stimulatory effect was confirmed by Bhatnagar et al. (1995) using the optimized medium KSOM. They found that CSF-1 accelerated the onset of blastocyst cavity formation and increased trophectodermal cell number bỹ 30%, without affecting cell numbers in the inner cell mass. This work is made even more interesting because of the results obtained in osteopetrotic mutant (op/op) mice which produce no CSF-1. Female op/op mice can become pregnant to wild-type males, but the percentage of mated animals becoming pregnant is markedly reduced, as is the number of implantation sites per pregnant animal . Matings of op/op females and males are infertile.
Added before the morula stage in mice, another cytokine, recombinant GM-CSF, inhibited development; at the morula stage it stimulated development (Robertson et al., 1991) and at the blastocyst stage it had no effect in physiological concentrations (Lea and Clark, 1993) . Haimovici et al. (1991) found that GM-CSF inhibited blastocyst implantation or attachment in vitro.
The role of interleukin-1 in implantation has been reviewed recently . An antagonist to the cytokine, interleukin-1, was found to block implantation in mice (Simón et al., 1994) . Interleukin-1 has been reported to block in-vitro attachment of mouse blastocysts onto fibronectin-coated supports (Haimovici and Anderson, 1993b) but to stimulate trophoblast outgrowth after blastocyst implantation in vitro (Haimovici and Anderson, 1993b; Muzikova and Clark, 1995) on laminin-coated surfaces. Interferon did not affect preimplantation mouse embryos in culture nor did it protect the embryos against encephalomyocarditis virus (Zusman et al., 1984; Carthew et al., 1986) ; similarly in cattle embryos it failed to induce an antiviral state (Bowen, 1988) . However, interferon-γ inhibited mouse blastocyst formation (Hill et al., 1987) and also trophoblast outgrowth after attachment of mouse blastocysts in vitro (Haimovici et al., 1991) . In cattle, there is evidence that interferon-τ derived from the embryos stimulates secretion of uterine proteins such as ubiquitin cross-reactive protein (Rueda et al., 1993; Naivar et al., 1995; Austin et al., 1996) .
There are some reports of embryonic effects of peptides not usually considered to be growth factors, e.g. parathyroid hormone-related peptide (PTHrP) was found to stimulate outgrowth of mouse trophectoderm in vitro (Behrendtsen et al., 1995) .
In summarizing these results on effects of added growth factors in embryonic development, one has a major difficulty in recognizing any clear pattern. If one considers the work on the mouse embryo alone, there are reports that mouse embryo growth is stimulated by EGF, TGF-α, insulin, IGF-I, IGF-II, TGF-β1, PDGF, CSF-1, LIF, GM-CSF, and, if one includes trophoblastic outgrowth, PDGF also. It must be emphasized that the mouse is a species in which one can readily culture 2-cell embryos to viable blastocysts in a protein-free medium consisting of a few simple salts and an energy source such as lactate or pyruvate (Cholewa and Whitten, 1970) . One answer to this problem is that autocrine secretion of growth factors may be important in embryo development; thus addition of exogenous growth factors may support this process under the stressful conditions of embryo culture. There is also some evidence that effects of growth factors on cultured embryos are most readily seen at the blastocyst stage, the stage at which in most species true growth starts and embryos start to increase their protein (Wright et al., 1981; Morgan and Kane, 1993) and dry matter (Turner et al., 1992) content (reviewed by Kane and Fahy, 1993) . However, what is disappointing about the work so far is the extent to which most studies on growth factors do not appear to contribute a meaningful improvement to embryo culture conditions; growth factor studies have not given risen to a situation where use of a particular growth factor has become standard practice in the culture of embryos of any species. Also, while there are some obvious exceptions, there also appear to be a large number of one-off studies. However, part of the reason for the failure to use growth factors on a routine basis in embryo culture may be the high cost of growth factors.
Conclusions
In summarizing the importance of the work on growth factors and preimplantation embryos to date, it is difficult to present any conclusions as to which growth factors may be most promising and at what stages. At least one of the reviewers (M.T.K.) feels that the beneficial effects of growth factors are most likely to emerge at blastocyst formation, with the start of net protein synthesis and true growth. There is less reason to believe that addition of growth factors will be beneficial for cleavage of embryos, unless possibly where embryos are cultured singly.
Based on the work reviewed here, the growth factors that appear most promising are CSF-1, FGF-4, IGF-I/IGF-II, TGF-α/EGF and possibly LIF.
For CSF-1 there are three lines of evidence which point to its potential importance in stimulating embryo development, at least in the mouse embryo. Firstly, there is evidence that the CSF-1 ligand is not expressed in the preimplantation mouse embryo, while the CSF-1 receptor is expressed in all stages from 2-cell embryo to blastocyst (Arceci et al., 1992a,b) . In contrast, high levels of CSF-1 ligand are expressed in the oviduct and uterus (Bartocci et al., 1986; Arceci et al., 1989 Arceci et al., , 1992a . Secondly, the evidence from work with osteopetrotic female mice which fail to produce CSF-1 indicates that the absence of maternal CSF-1 causes a reduction in implantation sites . Thirdly, culture studies indicate that CSF-1 stimulates blastocyst development , accelerates blastocoele formation and increases numbers of trophectodermal but not inner cell mass cells (Bhatnagar et al., 1995) .
Another promising growth factor is FGF-4. Here, the exciting findings are those of Feldman et al. (1995) that deletion of the FGF-4 gene leads to early postimplantation death and that embryos with FGF-4 gene deletions require exogenous FGF-4 to develop to blastocysts in vitro. Confirmation of these findings is desirable. There are also some culture studies showing effects of FGF on rabbit blastocysts (Hrabé de Angelis and Kirchner, 1993b; Hrabé de Angelis et al., 1995) .
The effects of IGF-I on cell number in mouse blastocysts are seen only under optimal culture conditions , which are the conditions likely to allow blastocysts to start true growth. The work of Rappolee et al. (1992) showing that antisense oligonucleotides to IGF-II inhibit cell proliferation of early mouse embryos and that this inhibition can be overcome by exogenous IGF-II provides strong evidence for an autocrine role for IGF-II in preimplantation embryos. Again, confirmation of these findings is desirable. Some of the culture work with TGF-α/EGF, particularly that of Hrabé de Angelis and Kirchner (1993a) on TGF-α in rabbit blastocysts, is promising; this promise is strengthened by the finding from knockout studies that deletion of the EGF receptor in at least one strain of mouse leads to abnormal inner cell mass development in early postimplantation stages.
The evidence for LIF is somewhat more problematical. While the main importance of LIF is in implantation, with the main effect being on preparation of the uterine site for implantation, there may also be some direct effect on the blastocyst (Stewart, 1994) . There is culture evidence in cattle and sheep that LIF stimulates blastocyst development Fukui and Matsuyama, 1994) .
This review has been confined to peptide growth factors; there is, however, increasing evidence that certain non-peptide factors may also act as growth factors using classical signal transduction systems. Examples are platelet-activating factor (PAF; see reviews by O'Neill, 1991; Pike et al., 1992; Ryan et al., 1992; Minhas et al., 1996) , lysophosphatidic acid (LPA; Jalink et al., 1994; Stachecki and Armant, 1996) and phosphatidic acid (English, 1996) . Exploration of the role of these and similar factors in early embryonic development may provide us with some interesting surprises.
